A new paradigm for personalized prophylaxis for patients with severe haemophilia A.

Xavier DelavenneEdouard OllierAnne LienhartDargaud Yesim

Published in: Haemophilia : the official journal of the World Federation of Hemophilia (2020)

Prophylactic FVIII dosing is more clinically meaningful when incorporating ETP alongside FVIII level. For the first time, FVIII dosing can be personalized with the aim of eliminating spontaneous breakthrough bleeds.

Keyphrases

early onset